No record found.

Startup

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Teva launches 'Teva Rise' to harness global innovation and transform healthcare

Digitization

WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing

WuXi Biologics launches PatroLab digital twin platform to transform biologics manufacturing

Thermo Fisher and NVIDIA team up to supercharge labs with AI

Thermo Fisher and NVIDIA team up to supercharge labs with AI

Revvity and Lilly partner to accelerate AI drug discovery models

Revvity and Lilly partner to accelerate AI drug discovery models

Latest Stories

Dr. David Berman to Join Moderna as Chief Development Officer

Hester Biosciences posts strong Q3 profit surge as poultry business powers growth

Strides posts record Q3 EBITDA of Rs. 235.9 crore, operational PAT Up 39% YoY

Indoco Remedies bags USFDA nod for Lacosamide oral solution

Dr Lal PathLabs reports Q3 revenue of Rs 660 crore, posts strong growth amid labour code impact

Opinion

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Metal-free catalysis is transforming future of sustainable pharmaceutical innovation

Interviews

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Only 4-5 Indian pharma companies have a strong presence in Russia but the opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Companies must shift from L1 costing to Life Cycle Cost Analysis: Abhilash Pasham, Associate GM - Central Engineering & Projects, Dr. Reddy's Laboratories

Packaging